3-(1H-imidazol-5-yl)-2-methylpropanoic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 3-(1H-imidazol-5-yl)-2-methylpropanoic acid
• 化学式: C₇H₁₀N₂O₂
• 分子量: 154.17
• InChiKey: ROVDFZZNEMZWJY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  66
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• SUBSTITUTED THIAZOLIDINEDIONE INDAZOLES, INDOLES AND BENZOTRIAZOLES AS ESTROGEN-RELATED RECEPTOR-a MODULATORS
  申请人：Bignan Gilles

  公开号：US20110294780A1

  公开（公告）日：2011-12-01

  The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating a condition including but not limited to ankylosing spondylitis, artherosclerosis, arthritis (such as rheumatoid arthritis, infectious arthritis, childhood arthritis, psoriatic arthritis, reactive arthritis), bone-related diseases (including those related to bone formation), breast cancer (including those unresponsive to anti-estrogen therapy), cardiovascular disorders, cartilage-related disease (such as cartilage injury/loss, cartilage degeneration, and those related to cartilage formation), chondrodysplasia, chondrosarcoma, chronic back injury, chronic bronchitis, chronic inflammatory airway disease, chronic obstructive pulmonary disease, diabetes, disorders of energy homeostasis, gout, pseudogout, lipid disorders, metabolic syndrome, multiple myeloma, obesity, osteoarthritis, osteogenesis imperfecta, osteolytic bone metastasis, osteomalacia, osteoporosis, Paget's disease, periodontal disease, polymyalgia rheumatica, Reiter's syndrome, repetitive stress injury, hyperglycemia, elevated blood glucose level, and insulin resistance.

  本发明涉及式(I)的化合物，制备这些化合物的方法，组合物，中间体及其衍生物，并用于治疗包括但不限于强直性脊柱炎，动脉粥样硬化，关节炎（如类风湿关节炎，感染性关节炎，儿童关节炎，银屑病性关节炎，反应性关节炎），与骨相关的疾病（包括与骨形成有关的疾病），乳腺癌（包括对抗雌激素治疗无效的癌症），心血管疾病，软骨相关疾病（如软骨损伤/丧失，软骨退化以及与软骨形成有关的疾病），软骨发育不良，软骨肉瘤，慢性腰部损伤，慢性支气管炎，慢性炎症性气道疾病，慢性阻塞性肺疾病，糖尿病，能量稳态紊乱，痛风，假性痛风，脂质紊乱，代谢综合征，多发性骨髓瘤，肥胖，骨关节炎，遗传性骨发育不全，骨溶解性骨转移，软骨软化症，骨质疏松症，帕金森病，牙周病，多肌痛风，Reiter综合征，重复性应激损伤，高血糖，血糖水平升高和胰岛素抵抗等病症的方法。
• [EN] COMPOSITIONS AND METHODS FOR MODULATING IMMUNITY IN PLANTS<br/>[FR] COMPOSITIONS ET PROCÉDÉS POUR MODULER L'IMMUNITÉ DANS DES PLANTES
  申请人：BOYCE THOMPSON INSTITUTE FOR PLANT RES INC

  公开号：WO2020214901A1

  公开（公告）日：2020-10-22

  Compositions and methods for protecting an organism from a pathogen are disclosed.

  揭示了一种保护生物体免受病原体侵害的组合物和方法。
• Novel Isocyanate And Isothiocyanate Compounds For Cancer Treatment
  申请人：Kalbe Jochen

  公开号：US20140228419A1

  公开（公告）日：2014-08-14

  The present invention relates to novel isocyanate and isothiocyanate compounds, to pharmaceutical compositions comprising them, and to the use thereof in the treatment of cancer diseases in humans and animals. The novel isocyanate and isothiocyanate compounds are distinguished, as compared with the known isocyanate and isothiocyanate compounds, by improved therapeutical breadth, i.e. fewer side effects while having high anti-tumor activity.

  本发明涉及新的异氰酸酯和异硫氰酸酯化合物，涉及包含它们的药物组合物，并涉及它们在人类和动物的癌症治疗中的应用。与已知的异氰酸酯和异硫氰酸酯化合物相比，这些新的异氰酸酯和异硫氰酸酯化合物通过改进的治疗广度，即在具有高抗肿瘤活性的同时减少副作用而得以区分。
• [EN] SOLID ORAL DOSAGE FORMS OF 2R,6R-HYDROXYNORKETAMINE OR DERIVATIVES THEREOF<br/>[FR] FORMES POSOLOGIQUES SOLIDES ORALES DE 2R, 6R-HYDROXYNORKÉTAMINE OU LEURS DÉRIVÉS
  申请人：SMALL PHARMA LTD

  公开号：WO2017208031A1

  公开（公告）日：2017-12-07

  This invention relates to solid oral dosage forms of 2R,6R-hydroxynorketamine or prodrugs thereof having Formula Ib, including any pharmaceutically acceptable salt of the foregoing, for use in a therapeutic method for the treatment of a depressive disorder in a patient.

  这项发明涉及具有公式Ib的2R,6R-羟基诺可胺或其前药的固体口服剂型，包括上述任何药用可接受盐，用于治疗患者的抑郁症的治疗方法。
• NOVEL 5-ACYLSULFANYL-HISTIDINE COMPOUNDS AS PRECURSORS OF THE CORRESPONDING 5-SULFANYLHISTIDINES AND THEIR DISULFIDES
  申请人：TETRAGEDRON

  公开号：US20170190691A1

  公开（公告）日：2017-07-06

  The invention relates to a compound of the 5-acylsulfanyl-histidine type and the derivatives thereof, of general formula (I), wherein R1 to R3=H, alkyl, especially CH3; R4=H, alkyl, especially CH3, alkyle(C═O), substituted alkyl (C═O), aryl (C═O); β-alanyl (H2NCH2CH2 (C═O); α-amino-acyl; R5=alkyl, especially methyl, phenyl. The invention also relates to the use of said compound for producing compounds of the 5-sulfanyl-histidine type and the derivatives thereof, in addition to corresponding disulfides; and to the various methods for the production thereof.

  本发明涉及一种5-酰基硫酰基组氨酸类化合物及其衍生物，通式（I）如下：其中R1至R3为H、烷基，特别是CH3；R4为H、烷基，特别是CH3，烷基（C═O）取代基烷基（C═O）、芳基（C═O）；β-丙氨酸基（H2NCH2CH2（C═O））；α-氨基酰基；R5为烷基，特别是甲基、苯基。本发明还涉及使用该化合物制备5-硫酰基组氨酸类化合物及其衍生物，以及相应的二硫化物；以及其制备的各种方法。